News Focus
News Focus

WID

Followers 1
Posts 489
Boards Moderated 0
Alias Born 03/29/2007

WID

Re: DewDiligence post# 5425

Monday, 09/29/2025 11:14:08 AM

Monday, September 29, 2025 11:14:08 AM

Post# of 6059
Our investment group is encouraged by ENTA’s Phase 2 RSV results. As Dew noted, the overall dataset appears robust and the presentation was clear. We would value your perspectives on the prospects for a partnership and the drug’s continued development. Thank you all for your time and insights.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News